
by BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Coming soon to iPhone. Already have it? “Open in Starcast” takes you straight there.
Who’s been on
Latest episodes
- Ep. 393 - China trends; Roche, Merck KGaA deals; Arrowhead & tau
- Ep. 392 - Biotech markets: Pause before the storm?
- Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners